2-trans-Dodecenoyl-Co A

References

• High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium tuberculosis
  • T. J. Sullivan, J. J. Truglio, M. E. Boyne, P. Novichenok, X. Zhang, C. F. Stratton, H.-J. Li, T. Kaur, A. Amin, F. Johnson, R. A. Slayden, C. Kisker, P. J. Tonge, ACS Chem. Biol. 2006, 1, 43.
• Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA
  • L. Encinas, H. O’Keefe, M. Neu, M. J. Remuiñán, A. M. Patel, A. Guardia, C. P. Davie, N. Pérez-Macías, H. Yang, M. A. Convery, J. A. Messer, E. Pérez-Herrán, P. A. Centrella, D. Álvarez-Gómez, M. A. Clark, S. Huss, G. K. O’Donovan, F. Ortega-Muro, W. McDowell, P. Castañeda, C. C. Arico-Muendel, S. Pajk, J. Rullás, I. Angulo-Barturen, E. Álvarez-Ruíz, A. Mendoza-Losana, L. B. Pages, J. Castro-Pichel, G. Evindar, J. Med. Chem. 2014, 57, 1276.
• Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography
  • P. Kamsri, C. Hanwarinroj, N. Phusi, T. Pornprom, K. Chayajarus, A. Punkvang, N. Suttipanta, P. Srimanote, K. Suttisintong, C. Songsiriritthigul, P. Saparpakorn, S. Hannongbua, S. Rattanabunyong, S. Seetaha, K. Choowongkomon, S. Sureram, P. Kittakoop, P. Hongmanee, P. Santanirand, Z. Chen, W. Zhu, R. A. Blood, Y. Takebayashi, P. Hinchliffe, A. J. Mulholland, J. Spencer, P. Pungpo, J. Chem. Inf. Model. 2020, 60, 226.
• Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis
  • S. Parikh, D. P. Moynihan, G. Xiao, P. J. Tonge, Biochemistry 1999, 38, 13623.